In focus · trending topic

fatty liver disease

3 stories · following the connections

Immuron Granted US Patent for NASH Treatment

By Nasdaq OMXNov 15, 2017, 2:00 PM UTC

Galectin Therapeutics CEO Peter G. Traber, M.D. Named Chair of the Anti-Fibrotic Drug Development Summit 2017

By Nasdaq OMXNov 13, 2017, 2:01 PM UTC

Galectin Therapeutics Reports 2017 Third Quarter Financial Results and Provides Business Update

By Nasdaq OMXNov 7, 2017, 1:15 PM UTC